⌘K
Loading ticker…
As of 2026-08-24, Axsome Therapeutics, Inc (AXSM) has a 3-month relative strength percentile of 27 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 56. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.8%, relative volume 0.41×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
AXSM is held by 35 ETFs as of May 2026. Top owner: VTWO at 0.28% weight, $50M notional. Top 3 carry $122M.
Held by 84 ETFs · $1.2B across latest filings · largest weight 4.59% (IBRN).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.28% | $50M | +0.07 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.21% | $48M | +0.05 pp |
| VHTVanguard Health Care ETF | 0.13% | $25M | +0.05 pp |
| VTWG | 0.54% | $9M | +0.11 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.01% | $6M | — |
| GSSC | 0.35% | $3M | +0.13 pp |
| VFMO | 0.18% | $3M | +0.01 pp |
| LFSC | 2.84% | $3M | +0.69 pp |
| ONEQ | 0.03% | $3M | — |
| DWAS | 0.64% | $3M | +0.10 pp |
Showing 10 of 35 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AXSM Jan avg: 9.26% median: 7.00% win: 75% σ: 12.96% n: 4 2022-04-12 → 2026-07-31 | AXSM Feb avg: -2.48% median: -9.34% win: 25% σ: 14.88% n: 4 2022-04-12 → 2026-07-31 | AXSM Mar avg: -4.23% median: -5.25% win: 25% σ: 5.96% n: 4 2022-04-12 → 2026-07-31 | AXSM Apr avg: 1.22% median: -3.72% win: 40% σ: 18.07% n: 5 2022-04-12 → 2026-07-31 | AXSM May avg: -2.41% median: -0.45% win: 40% σ: 12.64% n: 5 2022-04-12 → 2026-07-31 | AXSM Jun avg: 12.78% median: 4.39% win: 60% σ: 23.09% n: 5 2022-04-12 → 2026-07-31 | AXSM Jul avg: 0.92% median: 0.76% win: 60% σ: 8.38% n: 5 2022-04-12 → 2026-07-31 | AXSM Aug avg: 22.43% median: 11.30% win: 100% σ: 29.74% n: 4 2022-04-12 → 2026-07-31 (current) | AXSM Sep avg: -10.57% median: -6.68% win: 50% σ: 14.61% n: 4 2022-04-12 → 2026-07-31 | AXSM Oct avg: 0.13% median: 0.13% win: 50% σ: 9.04% n: 4 2022-04-12 → 2026-07-31 | AXSM Nov avg: 22.74% median: 11.28% win: 100% σ: 24.96% n: 4 2022-04-12 → 2026-07-31 | AXSM Dec avg: 7.85% median: 12.35% win: 75% σ: 15.67% n: 4 2022-04-12 → 2026-07-31 |